Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-039521
Filing Date
2021-06-10
Accepted
2021-06-10 16:57:28
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3143
  Complete submission text file 0001209191-21-039521.txt   4485
Mailing Address 11119 NORTH TORREY PINES RD #200 LA JOLLA CA 92037
Business Address
FOEHR MATTHEW W (Reporting) CIK: 0001237556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 211008758

Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations